Mark Osterman Email & Phone Number

Hyderabad, Ts, In

Raleigh, North Carolina, Us

Led multiple global life sciences organizations on product and company valuation and portfolio prioritization resulting in successful clinical and commercial programs.

Established consulting company specializing in commercial/marketing strategyCurrent client included pre-IND, NDA, and Large Pharma

Created business strategy, financial model, and launch plan for medication compliance start up. Responsible for finance, marketing, sales, and business development of key technology. Developed financing strategy for first round of funding with Angel and VC partners.

Establish turnaround marketing strategy for MYOBLOC. Established new marketing, reimbursement, business development, and corporate communication plan. Managed international partners through launch of brand in EU, Japan, and Korea. Managed 35 person commercial organizationRestructured existing marketing, reimbursement, and communication groups. Provided interim leadership for sales organization Launched new marketing campaign and trained sales organization Led business development for out/in licensing initiativesCreated new reimbursement strategy for transition of in-house operations and field based organization

Recruited by CEO to established internal commercial organization and terminated contract commercial obligations. Recruited, developed, and implemented commercial launch strategy and execution for Surfaxin. Directed company through transition from R&D to a commercial organization. Recruited and managed 24 person commercial organizationCreated a new sales, marketing, and distribution organization in eight months. Identified and recruited top organizational talent for entry into Neonatal/Inhalation Technology market.Successfully led commercial organization through challenging environment. (regulatory, cultural, financial)Negotiated new partnership agreements and restructured/terminated current agreements.Coordinated potential OUS partner identification and due diligence for pan-European, Japanese, and International markets to increase control and competitive advantage.Presented corporate overview and strategy at numerous investment and partnership conferences.Created and implemented the new vision, mission, and values which guided compensation and performance planning.

New Brunswick, Nj, Us

Recruited by former Centocor CEO to create new internal and external investment strategy within the venture capital division of J&J. Managed 23 person internal ventureRaised significant financing to align the J&J stem cell strategy both internally and externally to reduce parallel investmentsEstablished Internal Venture division within Johnson & Johnson for long-term innovation and entrepreneurial leadership. Launched new venture and created business unit to support cellular therapy for Cardiovascular disease.Led commercial due diligence for the acquisition of Scios ($2.44 billion) within a two month period.Recognized as high potential candidate and offered extensive management and leadership training based upon consistently exceeding corporation performance metrics.

Us

Championed the cardiovascular, pulmonary, metabolism, and infectious disease therapeutic areas. Launched the pulmonary and metabolism therapeutic areas for Centocor. Involved in numerous business development projects related to areas of responsibility. Launched the business unit for the MIMETIBODY* platform with responsibility for building business plan. Managed 11 person department

Brentford, Middlesex, Gb

Coordinated and executed the international strategic launch plan for Ariflo that included marketing, sales, regulatory, clinical, public relations, pricing, health economics, and life cycle management.Presented strategic development plan to key European markets, International markets, and the UnitedStates. Evaluated line extensions and commercial partnerships for building respiratory franchise.

Brentford, Middlesex, Gb

Developed marketing launch plan for two new indications, COPD and Pediatrics. Developed market overview, market strategy, position and message. Created strategy and tactics for success in the approximately $2.7 billion Asthma/COPD market.

Brentford, Middlesex, Gb

Established long term relationships and partnerships with internationally recognized thought leaders/researchers, including: biotechnology companies like Kimeragen, Molecular Tool; research institutions

Brentford, Middlesex, Gb

Ba, Business Management

B.A, Economics

Executive Education, Finance For Senior Executives